Delivery Order SPE2DB22D3301-SPE2DB25FZ0LU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Ceftriaxone 2 GM-D5W bags with a ceiling value of $1,977.90. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement practices. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026,...
- The Defense Logistics Agency awarded a delivery order valued at $9,224.08 to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, an antibiotic medication commonly used in military and federal healthcare systems. The contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. Performance will be completed by August 13, 2025, with the product supplied from AmerisourceBergen's location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,352.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ceftriaxone 2 GM-D5W bags, with an ultimate completion date of August 20, 2025. This award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside designation, and performance...
- The Defense Logistics Agency awarded a $2,248.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of Ceftriaxone 1 GM-D5W bags with a ceiling value of $3,436.68. This firm fixed-price delivery order, which is expected to be completed by August 6, 2025, represents a competitively awarded, non-set-aside contract and will be performed at the contractor's Conshohocken facility. Ceftriaxone...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ceftriaxone 2 GM-D5W bags with a ceiling value of $7,765.88. This non-competitive delivery order, issued on September 9, 2025, represents a firm fixed-price pharmaceutical procurement supporting federal medical supply requirements. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ceftriaxone 2 GM-D5W bags with a ceiling value of $3,111.71. This is a firm fixed price delivery order with no set-aside designation, awarded competitively on August 19, 2025, with an ultimate completion date of August 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, a broad-spectrum antibiotic commonly used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $5,353.10, is scheduled for completion by August 14, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,978.19 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 1 GM-D5W bags, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ceftriaxone is a third-generation cephalosporin antibiotic commonly used throughout military and federal...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, a common antibiotic medication used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $2,890.58, represents a non-set-aside competitive award with an ultimate completion date of July 22, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0LUDelivery Order
The Defense Logistics Agency awarded a $18,599.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for Ceftriaxone 2 GM-D5W bags, with performance to be completed by September 5, 2025. This non-set-aside contract is a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare systems through competitive federal contracting. Ceftriaxone is a broad-spectrum antibiotic commonly used in military medical supply chains for treating bacterial infections across deployed and domestic military facilities. This delivery order represents a routine pharmaceutical transaction within AmerisourceBergen's extensive portfolio of medications and medical supplies supporting the Defense Health Agency and broader Department of Defense healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.6k | 9/4/25 |